Apellis Medical Hub
  • Science
    • PNH
    • Geographic Atrophy
    • C3G and Primary IC-MPGN
    • HSCT-TMA
    • Pipeline
  • Medical Research
    • Scientific Focus
    • Investigator Initiated Trials
    • Collaborative Research
    • Medical Writing Grants
    • Exploratory Data Analysis
  • Congress & Manuscripts
    • Congress Presentations
    • Manuscripts
  • Resources
    • Medical Information
    • Early Access & Compassionate Use Program
    • Prescribing Information
    • Community Letters
  • Search
  • This website is intended only for use by U.S. Healthcare Professionals.
  • Menu Menu
  • Science
    • PNH
    • Geographic Atrophy
    • C3G and Primary IC-MPGN
    • HSCT-TMA
    • Pipeline
  • Medical Research
    • Scientific Focus
    • Investigator Initiated Trials
    • Collaborative Research
    • Medical Writing Grants
    • Exploratory Data Analysis
  • Congress & Manuscripts
    • Congress Presentations
    • Manuscripts
  • Resources
    • Medical Information
    • Early Access & Compassionate Use Program
    • Prescribing Information
    • Community Letters
  • Search
  • This website is intended only for use by U.S. Healthcare Professionals.
Home / Congress Presentations / Paroxsymal Nocturnal Hemoglobinuria (PNH)

Paroxsymal Nocturnal Hemoglobinuria (PNH)

Here you can find materials related to Apellis presentations at congresses

The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.

The following information for US Healthcare Professionals includes links to Apellis-sponsored congress presentations that have been presented at scientific meetings. The list of presentations below may contain information about doses, uses, formulations and populations different from product labeling or contain information about investigational compounds or uses not approved by a regulatory authority. The following list of presentations is not comprehensive or exhaustive as to any particular topic. Apellis does not suggest or recommend the use of its products in any manner other than as described in the Prescribing Information. Please refer to the product’s full Prescribing Information.

By selecting a congress, you’re confirming that your query is unsolicited.

Search Presentations

Latest Congresses

Classical Hematology Conference: Nonmalignant Hematology and Bleeding and Thrombotic Disorders 2024

15 – 17 October

Society of Hematologic Oncology (SOHO) 2024

4 – 7 September

Past Congresses

European Hematology Association (EHA) 2024
13-16 June 2024

International AAMDSIF Bone Marrow Failure Disease Scientific Symposium (AAMDSIF BMF) 2024
21-22 March 2024

International Congress on Hematologic Malignancies (HEM) 2024
29 Feb-3 March 2024

American Society of Hematology (ASH) 2023
9-12 December 2023

International Society for Pharmacoeconomics and Outcomes Research Europe (ISPOR EU) 2023
12-15 November 2023

Aplastic Anemia & MDS International Foundation (AAMDSIF) 2023
26-27 October 2023

Society for Medical Decision Making (SMDM) 2023
22-25 October 2023

Academy of Managed Care Pharmacy Nexus (AMCP Nexus) 2023
16-19 October 2023

National Organization for Rare Disorders (NORD) 2023
15-17 October 2023

Society of Hematologic Oncology (SOHO) 2023
6-9 September 2023

International Conference on Pharmacoepidemiology (ICPE) 2023
23-27 August 2023

European Hematology Association (EHA) 2023
8-11 June 2023

International PNH Interest Group (IPIG) Conference 2023
18-19 May 2023

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2023
7-10 May 2023

Oncology Nursing Society Congress (ONS) 2023
26-30 April 2023

European Society for Blood and Marrow Transplantation (EBMT) 2023
23-26 April 2023

International Congress on Hematologic Malignancies (HEM) 2023
24-27 February 2023

To learn more about Apellis clinical trials go to www.clinicaltrials.gov
Please refer to the U.S. Prescribing Information for EMPAVELI®

The safety and efficacy of the agents for the indications under investigation have not been established. There is no guarantee that the outcome of these studies will result in approval by a Health Authority.

Report an Adverse Event or Product complaint

Please call 833-866-3346

Ask a Medical Question

Please click here or call
833-866-3346 (833-TO-MEDINFO)

Connect with an MSL

Set up a meeting with your
Medical Science Liaison

Privacy PolicyTerms and Conditions

©2025 Apellis Pharmaceuticals, Inc. All rights reserved. 04/25 MED-US-CORP-22-00001 v11.0
Scroll to top
You are now leaving ApellisMedicalHub.com

You are about to leave ApellisMedicalHub.com to visit a third-party website. We recommend reviewing the privacy policy and terms & conditions of any site you visit, as Apellis Pharmaceuticals, Inc. is not responsible for their content.

I agree
Landing

Landing

You are entering a website that is technical in nature and was created for scientific exchange with Healthcare Professionals. The content on this website may include scientific information about investigational compounds or indications that are not approved. Apellis does not support, endorse or recommend the unapproved use of any compound, including those discussed on this website.
Are you a Healthcare Professional licensed to practice in the country or region selected above? If you are not a Healthcare Professional, you will be redirected to www.apellis.com(Required)
Enter
Enter
Enter
Enter
Enter
Enter